N/A N=47 A Clinician-Focused Nudging Intervention to Optimize Post-Surgical Prescribing
Opioid Prescribing · Surgical Procedure, Unspecified
Primary: Percentage of Surgeons Approached Who Agree to Participate — 47 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=270 Self-Management of Continuous Positive Airway Pressure Settings
Obstructive Sleep Apnea
Primary: Treatment Adherence — 2.1; 2.2 Hours per night
Phase 1 N=32 A Study to Evaluate Plasma Gelsolin in Healthy Volunteers
Volunteers · Healthy
Primary: Adverse Events — 1; 2; 3; 2 Participants
N/A N=58 Love Infection: A Dramatized Story Intervention (Telenovela/Soap Opera) for HIV Prevention
HIV Infections
Primary: Mean Condom Use — 0.50; 0.14; 1.30; 0.52 sexual episodes
N/A N=115 Cognitive Rehab and Exposure Treatment for Hoarding
Hoarding Disorder
Primary: Saving Inventory Revised — 59.9; 55.3; 25.2; 23.0 score on a scale
N/A N=31 Survivor mHealth: Wearable Devices in Cancer Survivors
Cancer · Cardiovascular Diseases
Primary: Feasibility of Enrollment — 30 Participants
N/A N=80 Randomized Trial Comparing Prediction Accuracy of Two Swept Source Optical Coherence Tomography Biometers
Cataract
Primary: Mean Absolute Prediction Error (D) — 0.21; 0.25 diopters
N/A N=40 Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Hemophagocytic Lymphohistiocytosis
Primary: Mean Serum Concentration of Inflammatory Biomarker - C-X-C Chemokine Ligand 10 (CXCL10) — 5040.638; 454.392 picogram/milliliter (pg/mL)
N/A N=16 Home-Based Dual-Task Training for Older Adults
Mild Cognitive Impairment
Primary: Change in Balance: Left Limb — 1.52; 0.05 Seconds — p=.001
Phase 2 N=98 Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease
Mild Cognitive Impairment · MCI · Aging
Primary: fMRI Measurement — 2267.0; 1491.23; 673.31; 989.19 voxels
Phase 4 N=240 A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
Migraine
Primary: Mean Change From Baseline in the Treatment Satisfaction Questionnaire for Medication (TSQM) Overall Satisfaction Scale Score at Week 24 by SoC — 42.33; 34.42 Score on a…
N/A N=215 Perceptual Training to Improve Listeners' Ability to Understand Speech Produced by Individuals With Dysarthria
Dysarthria · Intelligibility, Speech
Primary: Pretest Transcription Accuracy — 77.8; 35.3; 52.9; 30 percentage of words correct
N/A N=36 Cannabidiol Effects on Blood Alcohol Level and Intoxication
Alcohol Use Disorder
Primary: Breath Alcohol Concentration (BrAC) — 0.065; .067; .070 g/dL
Phase 1 N=9 Caffeine for Hypoxic-Ischemic Encephalopathy
Hypoxic-Ischemic Encephalopathy
Primary: Area Under Plasma Concentration-time at Time t (AUC0-t) for Caffeine — 1137.36; 1177.94; 2213.26; 2768.25 mg*hr/L
N/A N=114 LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19
Bowel Cancer · Bowel Diseases, Inflammatory · Rectal Bleeding
Primary: Patient Experience of LumenEye Examination — 75; 67; 95; 94 percentage of participants